AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2021
Dec 15, 2021
31982_dirs_2021-12-15_c73373fc-3212-4c9a-b8b2-00fb22cce3a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2021-12-13
Reporting Person: DOUGLAS RICHARD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-13 | Common Stock | M | 1500 | $25.60 | Acquired | 33450 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-13 | Stock Option (Right to Buy) | $25.60 | M | 1500 | Disposed | 2022-03-01 | Common Stock (1500) | Direct |
More from NOVAVAX INC
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 26
Director's Dealing
2026
Jan 26